Panodyne COVID-19 Antibody Rapid Test Kit

SKU: PDCTKCT-U

£1.99 £9.99

Overview

COVID-19, it is a novel coronavirus with new strain that has not been previously identified in humans, belongs to Coronaviruses (CoV) such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).

 

Panodyne COVID-19 Antibody Rapid Test Kit Benefits

  • Sample Volume: 10μl
  • Fast Reaction: 15 minutes
  • For professional use only

Kit contents

  • Test cassette
  • Alcohol wipe
  • Extraction buffer
  • Pipette
  • Sterile lancet

Organisations and businesses who already are or wish to implement a test tracking program, please click on the link below to download the Panodyne COVID-19 Antibody Rapid Test Kit declaration form for subjects to sign and for your records. The declaration form can be used for research and consent form purposes only.

Download the Declaration form

Intended use

Used to detect the IgM and IgG antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human serum, plasma or whole blood sample qualitatively. It is to be used as an aid in the diagnosis of coronavirus infection disease (COVID-19), which is caused by SARS-CoV-2.

  • Sensitivity: 94.15%
  • Specificity: 93.91%
  • Total Consistent: 94%

Note: Results compared to Molecular testing.

Serum/Plasma/Whole Blood

  1. Add 10μl of serum/plasma/whole blood vertically into the sample well
  2. Add two drops (70μl) of sample buffer into the sample well
  3. Read results within 10~15 minutes, the result is invalid over 20 minutes

Since its establishment in August 2020, the joint UK Health Security Agency (UKHSA) Porton Down and University of Oxford SARS-CoV-2 lateral flow antigen test validation cell has evaluated over 160 lateral flow devices that have been referred by the Department of Health and Social Care.

Read further information about Panodyne COVID-19 ANTIGEN RAPID TEST KIT passing phase 3 validation:

https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/outcome-of-the-evaluation-of-rapid-diagnostic-assays-for-specific-sars-cov-2-antigens-lateral-flow-devices?msclkid=6d3f1c04aeb211ecbe3f371d07e72772

Recently viewed